{
  "id": 567961,
  "title": "Epicrispr secures $90M after early data on epigenetic FSHD treatment",
  "url": "https://urgent.news/2026/08/11/epicrispr-secures-90m-after-early-data-on-epigenetic-fshd-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-11T12:54:59.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/epicrispr-secures-90m-after-early-data-on-epigenetic-fshd-treatment/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Epicrispr Biotechnologies has raised $90 million for its Series C round after sharing promising early data around a potential new way to treat a rare muscle disease called facioscapulohumeral muscular dystrophy. The Series C was ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}